Management of heaves

Equine Veterinary Education

Volumn 13, Issue 5, 2001, Pages 247-259

  Robinson, N E ^a   Derksen, F J ^a   Jackson, C A ^a   Peroni, D ^a   Gerber, V ^a  

^a MICHIGAN STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0035618755     PISSN: 09577734     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.2042-3292.2001.tb00104.x     Document Type: Article

References (102)

1. Anon (1997) Report 2: Guidelines for the Diagnosis and Management of Asthma. National Asthma Eduation and Prevention Program Expert Panel, Washington DC, US Government Printing Office. NIH - NHLBI Publication No. 97-4051.
2. Anon (2000) Proceedings of the American Thoracic Society workshop on refractory asthma: current understanding, recommendations, and unanswered questions. Am. J. respir. crit. care Med. 162, 2341-2351.
3. Ammann, V.J., Vrins, A.A. and Lavoie, J.-P. (1998) Effects of inhaled beclomethasone dipropionate on respiratory function in horses with chronic obstructive pulmonary disease (COPD) Equine vet. J. 30, 152-157.
4. Art, T., Kirschvink, N., Smith, N. and Lekeux, P. (1999a) Indices of oxidative stress in blood and pulmonary epithelium lining fluid in horses suffering from recurrent airway obstruction. Equine vet. J. 31, 397-401.
5. Art, T., Kirschvink, N., Smith, N., Votion, D. and Lekeux, P. (1999b) Cardiorespiratory measurements and indices of oxidative stress in exercising COPD horses. Equine vet. J., Suppl. 30, 83-87.
6. Aviza, G.A., Ainsworth, D.M., Eicker, S.W., Santiago, M.A., Divers, T.J. and Perkins, G.A. (2001) Outcome of horses diagnosed and treated for heaves (recurrent airway obstruction). Equine vet. Educ. 13, 243-246.
7. Barnes, N. (1998a) Relative safety and efficacy of inhaled corticosteroids. J. Allergy clin. Immunol. 101, S460-464.
8. Barnes, P.J. (1997) Molecular mechanisms of glucocorticoid action in asthma. Pulm. Pharmacol. Ther. 10, 3-19.
9. Barnes, P.J. (1998b) Current issues for establishing inhaled corticosteroids as the anti-inflammatory agents of choice in asthma. J. Allergy clin. Immunol. 101, S427-433.
10. Barnes, P.J., Pedersen, S. and Busse, W.W. (1998) Efficacy and safety of inhaled corticosteroids. New developments. Am. J. respir. crit. care Med. 157, S1-53.
11. Breeze, R.G. (1979) The problem of disease definition. Vet. Clin. N. Am.: Large Anim. Pract. 1, 219-230.
12. Broadstone, R.V., Scott, J.S., Derksen, F.J. and Robinson, N.E. (1988) Effects of atropine in ponies with recurrent airway obstruction. J. appl. Physiol. 65, 2720-2725.
13. Broadstone, R.V., Gray, P.G., Robinson, N.E. and Derksen, F.J. (1992) Effects of xylazine on airway function in ponies with recurrent airway obstruction. Am. J. vet. Res. 53, 1813-1817.
14. Broadstone, R.V., Robinson, N.E., Gray, P.R., Woods, P.S.A. and Derksen, F.J. (1991) Effects of furosemide on ponies with recurrent airway obstruction. Pulm. Pharmacol. 4, 203-208.
15. Bureau, F., Bonizzi, G., Kirschvink, N., Delhalle, S., Desmecht, D., Merville, M.-P., Bours, V. and Lekeux, P. (2000a) Correlation between nuclear factor-B activity in bronchial brushing samples and lung dysfunction in an animal model of asthma. Am. J. respir. crit. care Med. 161, 1314-1321.
16. Bureau, F., Delhalle, S., Bonizzi, G., Fiévez, L., Dogné, S., Kirschvink, N., Merville, M.-P., Bours, V. and Lekeux, P. (2000b) An autocrine mechanism maintains persistent NF-B activation in the bronchi of an animal model of asthma. Am. J. respir. crit. care Med. 161, A330.
17. Burrell, M.H., Wood, J.L.N., Whitwell, K.E., Chanter, N., Mackintosh, M.E. and Mumford, J.A. (1996) Respiratory disease in Thoroughbred horses in training: the relationships between disease and viruses, bacteria and environment. Vet. Rec. 139, 308-313.
18. Cookson, W.O. and Moffatt, M.F. (2000) Genetics of asthma and allergic disease. Hum. mol. Gen. 9, 2359-2364.
19. Cunningham, F.E., Rogers, S., Fischer, J.H. and Jensen, R.C. (1996) The pharmacokinetics of dexamethasone in the Thoroughbred racehorse. J. vet. Pharmacol. Ther. 19, 68-71.
20. Derksen, F.J., Scott, J.S., Miller, D.C., Slocombe, R.F. and Robinson, N.E. (1985) Bronchoalveolar lavage in ponies with recurrent airway obstruction (heaves).Am. Rev. respir. Dis. 132, 1066-1070.
21. Derksen, F.J., Brown, C.M., Sonea, I., Darien, B.J. and Robinson, N.E. (1989) Comparison of transtracheal aspirate and bronchoalveolar lavage cytology in 50 horses with chronic lung disease. Equine vet. J. 21, 23-26.
22. Derksen, F.J., Olszewski, M.A., Robinson, N.E., Berney, C.E., Hakala, J.E., Matson, C.J. and Ruth, D.T. (1999) Aerosolized albuterol sulfate used as a bronchodilator in horses with recurrent airway obstruction. Am. J. vet. Res. 60, 689-693.
23. Derksen, F.J., Olszewski, M., Robinson, N.E., Berney, C., Lloyd, J. W., Hakala, J., Matson, C. and Ruth, D. (1996) Use of a hand-held, metered-dose aerosol delivery device to administer pirbuterol acetate to horses with 'heaves'. Equine vet. J. 28, 306-310.
24. Dixon, P.M. (1978) Pulmonary artery pressure in normal horses and in horses affected with chronic obstructive pulmonary disease. Equine vet. J. 10, 195-198.
25. Dixon, P.M., Railton, D.I. and McGorum, B.C. (1995) Equine pulmonary disease: a case control study of 300 referred cases. Part 2: details of animals and historical and clinical findings. Equine vet. J. 27, 422-427.
26. Duvivier, D.H., Votion, D., Vandenput, S., Art, T. and Lekeux, P. (1997) Airway response of horses with COPD to dry powder inhalation of ipratropium bromide. Vet. J. 154, 149-53.
27. Erichsen, D.F., Aviad, A.D., Schultz, R.H. and Kennedy, T.J. (1994) Clinical efficacy and safety of clenbuterol HCl when administered to effect in horses with chronic obstructive pulmonary disease. Equine vet. J. 26, 331-336.
28. Fairbairn, S.M., Page, C.P., Lees, P. and Cunningham, F.M. (1993a) Early neutrophil but not eosinophil or platelet recruitment to the lungs of allergic horses following antigen exposure. Clin. expt. Allergy 23, 821-828.
29. Fairbairn, S.M., Lees, P., Page, C.P. and Cunningham, F.M. (1993b) Duration of antigen-induced hyperresponsiveness in horses with allergic respiratory disease and possible links with early airway obstruction. J. vet. Pharmacol. Therap. 16, 469-476.
30. Franchini, M., Gill, U., von Fellenberg, R. and Bracher, V.D. (2000) Interleukin-8 concentration and neutrophil chemotactic activity in bronchoalveolar lavage fluid of horses with chronic obstructive pulmonary disease following exposure to hay. Am. J. vet. Res. 61, 1369-1374.
31. Gerber, H. (1968) [On the treatment of chronic respiratory diseases in horses]. Schweiz. Arch. Tierheilkd. 110, 139-53.
32. Gerber, V., King, M., Schneider, D.A. and Robinson, N.E. (2000) Mucus viscoelasticity and clearability during environmental challenge in horses with recurrent airway obstruction. Equine vet. J. 32, 411-417.
33. Gerber, V., Straub, R., Schott, H.C. and Robinson, N.E. (2001b) Is mild airway inflammation and mucus accumulation really clinically significant? In: Second Symposium on Allergic Diseases of the Horse, R&W Publications, Newmarket, p 10.
34. Gerber, V., Hotchkiss, J.A., Rawson, J., Jefcoat, A.M. and Robinson, N.E. (2001a) MUC5AC but not MUC2 is expressed in equine airways. Am. Coll. vet. int. Med. 19, 89.
35. Gray, P.R., Derksen, F.J., Robinson, N.E., Carpenter-Deyo, L.J., Johnson, H.G. and Roth, R.A. (1989) The role of cyclooxygenase products in the acute airway obstruction and airway hyperreactivity of ponies with heaves. Am. Rev. respir. Dis. 140, 154-160.
36. Gray, P.R., Derksen, F.J., Broadstone, R.V., Robinson, N.E., Johnson, H.G. and Olson, N.C. (1992) Increased pulmonary production of immunoreactive 15-hydroxyeicosatetraenoic acid in an animal model of asthma. Am. Rev. respir. Dis. 145, 1092-1097.
37. Grebe, S.K., Feek, C.M., Durham, J.A., Kljakovic, M. and Cooke, R.R. (1997) Inhaled beclomethasone dipropionate suppresses the hypothalamo-pituitary-adrenal axis in a dose dependent manner. Clin. Endocrinol. (Oxf.) 47, 297-304.
38. Hare, J.E., Viel, L., Conlon, P.D. and O'Byrne, P.M. (1994) The effect of sodium cromoglycate on light racehorses with elevated metachronomatic cell numbers on bronchoalveolar lavage and reduced exercise tolerance. J. vet. Pharmacol. Therap. 17, 237-244.
39. Henrikson, S.L. and Rush, B.R. (2001) Efficacy of salmeterol xinafoate in horses with recurrent airway obstruction. J. Am. vet. med. Ass. 218, 1961-1965.
40. Holcombe, S.J., Jackson, C., Gerber, V., Jefcoat, A., Berney, C., Eberhardt, S. and Robinson, N.E. (2001) Stabling is associated with airway inflammation in young Arabian horses. Equine vet. J. 33, 244-249.
41. Jackson, C.A., Berney, C., Jefcoat, A.M. and Robinson, N.E. (2000) Environment and prednisone interactions in the treatment of recurrent airway obstruction (heaves). Equine vet. J. 32, 432-438.
42. Jackson, C.A., Robinson, N.E., Berney, C.E.A., Jefcoat, A.M. and Derksen, F.J. (1999) Prednisone - is it really effective in the treatment of chronic obstructive pulmonary disease? Proc. Am. Ass. equine Practnrs. 45, 304-305.
43. Jefcoat, A.M., Hotchkiss, J.A., Harkema, J.R., Basbaum, C.B. and Robinson, N.E. (2001) Persistent mucin glycoprotein alterations in equine recurrent airway obstruction. Am. J. Physiol. 281, L704-L712.
44. Johnson, M. (1998) The beta-adrenoceptor. Am. J. respir. crit. care Med. 158, S146-153.
45. Kaup, F.-J., Drommer, W. and Deegen, E. (1990b) Ultrastructural findings in horses with chronic obstructive pulmonary disease (COPD) I: alterations of the larger conducting airways. Equine vet. J. 22, 343-348.
46. Kaup, F.-J., Drommer, W., Damsch, S. and Deegen, E. (1990a) Ultrastructural findings in horses with chronic obstructive pulmonary disease (COPD) II: pathomorphological changes of the terminal airways and the alveolar region. Equine vet. J. 22, 349-355.
47. Konig, P. (2000) The effects of cromolyn sodium and nedocromil sodium in early asthma prevention. J. Allergy clin. Immunol. 105, S575-581.
48. LaPointe, J.-M., Lavoie, J.-P. and Vrins, A.A. (1993) Effects of triamcinolone acetonide on pulmonary function and bronchoalveolar lavage cytologic features in horses with chronic obstructive pulmonary disease. Am. J. vet. Res. 54, 1310-1316.
49. Lipworth, B.J. (1999) Systemic adverse effects of inhaled corticosteroid therapy: A systematic review and meta-analysis. Arch. int. Med. 159, 941-955.
50. 2-agonist with prolonged duration of action. Lung 171, 249-264.
51. Lowell, F.C. (1964) Observations on heaves: an asthma-like syndrome in the horse. J. Allergy 35, 322-330.
52. Malikides, N., Hughes, K., Matthews, S., Dowling, B., Dart, A., Hodgson, D.R. and Hodgson, J.L. (2001) Evaluation of tracheal wash and bronchoalveolar lavage for diagnosis of airway inflammation after exercise in horses with poor performance. In: Proceedings of the 2nd World Equine Airway Symposium.
53. Mansmann, R.A. and Knight, H.D. (1972) Transtracheal aspiration in the horse. J. Am. vet. med. Ass. 160, 1527-1529.
54. Markham, G. (1656) Markhams Maister-peece: Containing All Knowledge Belonging to the Smith, Farrier, or Horse-leech. W. Wilson, London.
55. Marti, E., Gerber, H., Essich, G., Oulehla, J. and Lazary, S. (1991) The genetic basis of equine allergic diseases 1. Chronic hypersensitivity bronchitis. Equine vet. J. 23, 457-460.
56. McGorum, B.C., Dixon, P.M. and Halliwell, R.E.W. (1993a) Quantification of histamine in plasma and pulmonary fluids from horses with chronic obstructive pulmonary disease, before and after 'natural (hay and straw) challenges'. Vet. Immunol. Immunopathol. 36, 223-237.
57. McGorum, B.C., Ellison, J. and Cullen, R.T. (1998) Total and respirable airborne dust endotoxin concentrations in three equine management systems. Equine vet. J. 30, 430-434.
58. McGorum, B.C., Dixon, P.M., Halliwell, R.E.W. and Irving, P. (1993b) Comparison of cellular and molecular components of bronchoalveolar lavage fluid harvested from different segments of the equine lung. Res. vet. Sci. 55, 57-59.
59. McKiernan, B.C., Koritz, G.D., Scott, J.S., Berney, C. and Robinson, N.E. (1990) Plasma theophylline concentration and lung function in ponies with recurrent obstructive lung disease. Equine vet. J. 22, 194-197.
60. McPherson, E.A., Lawson, G.H.K., Murphy, J.R., Nicholson, J.M., Fraser, J.A., Breeze, R.G. and Pirie, H.M. (1978) Chronic obstructive pulmonary disease (COPD): Identification of affected horses. Equine vet. J. 10, 47-53.
61. Moore, B.R., Krakawa, S., Robertson, J.T. and Cummins, J.M. (1995) Cytologic evaluation of bronchoalveolar lavage fluid obtained from Standardbred racehorses with inflammatory airway disease. Am. J. vet. Res. 56, 562-567.
62. Murphy, J.R., McPherson, E.A. and Dixon, P.M. (1980) Chronic obstructive pulmonary disease (COPD): effects of bronchodilator drugs on normal and affected horses. Equine vet. J. 12, 10-14.
63. Nyman, G., Lindberg, R., Weckner, D., Björk, M., Kvart, C. and Persson, S.G.B., Gustafsson, H. and Hedenstierna, G. (1991) Pulmonary gas exchange correlated to clinical signs and lung pathology in horses with chronic bronchiolitis. Equine vet. J. 23, 253-260.
64. O'Byrne, P.M. and Pedersen, S. (1998) Measuring efficacy and safety of different inhaled corticosteroid preparations. J. Allergy clin. Immunol. 102, 879-886.
65. Olszewski, M.A., Zhang, X.Y. and Robinson, N.E. (1999b) Pre- and postjunctional effects of inflammatory mediators in horse airways. Am. J. Physiol. 277, L327-L333.
66. Olszewski, M.A., Robinson, N.E., Zhou, F.X., Zhang, X.Y. and Tithof, P.K. (1999a) Mediators of anaphylaxis but not activated neutrophils augment cholinergic responses of equine small airways. Am. J. Physiol. 276, L522-529.
67. Pearson, E.G. and Riebold, T.W. (1989) Comparison of bronchodilators in alleviating clinical signs in horses with chronic obstructive pulmonary disease. J. Am. vet. med. Ass. 194, 1287-1291.
68. Raulo, S.M., Sorsa, T.A. and Maisi, P.S. (2000) Concentrations of elastinolytic metalloproteinases in respiratory tract secretions of healthy horses and horses with chronic obstructive pulmonary disease. Am. J. vet. Res. 61, 1067-1073.
69. Robinson, N.E. (2001) Chairperson's introduction: International workshop on equine chronic airway disease. Equine vet. J. 33, 5-19.
70. Robinson, N.E., Berney, C.E. and Peroni, D. (2001a) Mechanisms of airway obstruction in heaves. In: Proceedings of the 2nd World Equine Airway Symposium.
71. Robinson, N.E., Derksen, F.J., Berney, C. and Goossens, L. (1993) The airway response of horses with recurrent airway obstruction (heaves) to aerosol administration of ipratropium bromide. Equine vet. J. 25, 299-303.
72. Robinson, N.E., Derksen, F.J., Olszewski, M.A. and Buechner-Maxwell, V.A. (1996) The pathogenesis of chronic obstructive pulmonary disease of horses. Br. vet. J. 152, 283-306.
73. Robinson, N.E., Jackson, C.A., Peroni, D. and Stanley, S. (2000a) Why is oral prednisone ineffective for treatment of heaves? Proc. Am. Ass. equine Practnrs. 46, 266-267.
74. Robinson, N.E., Olszewski, M., Berney, C., Hakala, J.E. and Derksen, F.J. (1994) Are clinical signs an indicator of the severity of airway obstruction? Proc. vet. respir. Symp. 13, A11.
75. Robinson, N.E., Jackson, C., Jefcoat, A., Berney, C., Peroni, D. and Derksen, F.J. (2001b) Efficacy of three corticosteroids for the treatment of recurrent airway obstruction (heaves). Equine vet. J. In Press.
76. Robinson, N.E., Olszewski, M.A., Boehler, D., Berney, C., Hakala, J., Matson, C. and Derksen, F.J. (2000b) Relationship between clinical signs and lung function in horses with recurrent airway obstruction (heaves) during a bronchodilator trial. Equine vet. J. 32, 393-400.
77. Rubie, S., Robinson, N.E., Stoll, M., Broadstone, R.V. and Derksen, F.J. (1993) Flunixin meglumine blocks frusemide-induced bronchodilation in horses with chronic obstructive pulmonary disease. Equine vet. J. 25, 138-142.
78. Rush, B.R., Flaminio, M.J., Matson, C.J., Hakala, J.E. and Shuman, W. (1998a) Cytologic evaluation of bronchoalveolar lavage fluid in horses with recurrent airway obstruction after aerosol and parenteral administration of beclomethasone dipropionate and dexamethasone, respectively. Am. J. vet. Res. 59, 1033-1038.
79. Rush, B.R., Hoskinson, J.J., Davis, E.G., Matson, C.J. and Hakala, J.E. (1999) Pulmonary distribution of aerosolized technetium Tc 99m pentetate after administration of a single dose of aerosolized albuterol sulfate in horses with recurrent airway obstruction. Am. J. vet. Res. 60, 764-769.
80. Rush, B.R., Raub, E.S., Rhoads, W.S., Matson, C.J., Hakala, J.E. and Gillespie, J.R. (1998b) Pulmonary function in horses with recurrent airway obstruction after aerosol and parenteral administration of beclomethasone dipropionate and dexamethasone, respectively. Am. J. vet. Res. 59, 1039-1043.
81. Rush, B.R., Raub, E.S., Thomsen, M.M., Davis, E.G., Matson, C.J. and Hakala, J.E. (2000) Pulmonary function and adrenal gland suppression with incremental doses of aerosolized beclomethasone dipropionate in horses with recurrent airway obstruction. J. Am. vet. med. Ass. 217, 359-364.
82. Sasse, H.H. and Hajer, R. (1977) [Veterinary and clinical experience of the use of a beta2-receptor-stimulating sympathicomimetic agent (NAB 365) in horses with respiratory disease]. Dutch. Tijdschr. Diergeneeskd. 102, 1233-1238.
83. Schwartz, L.W., Knight, H.D., Whittig, L.D., Malloy, R.L., Abraham, J.L. and Tyler, N.K. (1981) Silicate pneumoconiosis and pulmonary fibrosis in horses from the Monterey-Carmel peninsula. Chest 80, 82-85.
84. Soma, L.R., Beech, J. and Gerber, N.H. (1987) Effects of cromolyn in horses with chronic obstructive pulmonary disease. Vet. res. Commun. 11, 339-351.
85. Sorkness, C.A. (1998) Establishing a therapeutic index for the inhaled corticosteroids: Part II, Comparisons of systemic activity and safety among different inhaled corticosteroids. J. Allergy clin. Immunol. 102, S52-64.
86. Sweeney, C.R., Humber, K.A. and Roby, K.A.W. (1992) Cytologic findings of tracheobronchial aspirates from 66 Thoroughbred racehorses. Am. J. vet. Res. 53, 1172-1175.
87. Tasche, M.J., Uijen, J.H., Bernsen, R.M., de Jongste, J.C. and van der Wouden, J.C. (2000) Inhaled disodium cromoglycate (DSCG) as maintenance therapy in children with asthma: a systematic review. Thorax 55, 913-920.
88. Tesarowski, D.B., Viel, L., McDonell, W.N. and Newhouse, M.T. (1994) The rapid and effective administration of a beta 2-agonist to horses with heaves using a compact inhalation device and metered-dose inhalers. Can. J. vet. Res. 35, 170-173.
89. Thomson, J.R. and McPherson, E.A. (1981) Prophylactic effects of sodium cromoglycate on chronic obstructive pulmonary disease in the horse. Equine vet. J. 13, 243-246.
90. Thomson, J.R. and McPherson, E.A. (1984) Effects of environmental control on pulmonary function of horses affected with chronic obstructive pulmonary disease. Equine vet. J. 16, 35-38.
91. Traub-Dargatz, J.L., McKinnon, A.O., Thrall, M.A., Jones, R.L., Bruyninckx, W., Blancquaert, A.M. and Dargatz, D.A. (1992) Evaluation of clinical signs of disease, bronchoalveolar and tracheal wash analysis, and arterial blood gas tensions in 13 horses with chronic obstructive pulmonary disease treated with prednisone, methyl sulfonmethane, and clenbuterol hydrochloride. Am. J. vet. Res. 53, 1908-1916.
92. Tremblay, G.M., Ferland, C., Lapointe, J.-M., Vrins, A., Lavoie, J.P. and Cormier, Y. (1993) Effect of stabling on bronchoalveolar cells obtained from normal and COPD horses. Equine vet. J. 25, 194-197.
93. Turgut, K. and Sasse, H.H. (1989) Influence of clenbuterol on mucociliary transport in healthy horses and horses with chronic obstructive pulmonary disease. Vet. Rec. 125, 526-530.
94. Vandenput, S., Istasse, L., Nicks, B. and Lekeux, P. (1997) Airborne dust and aeroallergen concentrations in different sources of feed and bedding for horses. Vet. Quart. 19, 154-158.
95. Vandenput, S., Duvivier, D.H., Votion, D., Art, T. and Lekeux, P. (1998a) Environmental control to maintain stabled COPD horses in clinical remission: effects on pulmonary function. Equine vet. J. 30, 93-96.
96. Vandenput, S., Votion, D., Duvivier, D., Van Erck, E., Anciaux, N., Art, T. and Lekeux, P. (1998b) Effect of a set stabled environmental control on pulmonary function and airway reactivity of COPD affected horses. Vet. J. 155, 189-195.
97. Viel, L., Celly, C., Staempfli, H. and Tesarowski, D.B. (1999) Therapeutic efficacy of inhaled fluticasone propionate in horses with chronic obstructive pulmonary disease. Proc. Am. Ass. equine Practnrs. 45, 306-307.
98. Votion, D., Ghafir, Y., Vandenput, S., Duvivier, D.H., Art, T. and Lekeux, P. (1999) Analysis of scintigraphical lung images before and after treatment of horses suffering from chronic pulmonary disease. Vet. Rec. 144, 232-236.
99. Watson, E.D., Sweeney, C.R. and Steensma, K.A. (1992) Arachidonate metabolites in bronchoalveolar lavage fluid from horses with and without COPD. Equine vet. J. 24, 379-381.
100. Woods, P.S., Robinson, N.E., Swanson, M.C., Reed, C.E., Broadstone, R.V. and Derksen, F.J. (1993) Airborne dust and aeroallergen concentration in a horse stable under two different management systems. Equine vet. J. 25, 208-213.
101. Yu, M., Wang, Z. and Robinson, N.E. (1993) Prejunctional alpha2-adrenoceptors inhibit acetylcholine release from cholinergic nerves in equine airways. Am. J. Physiol. 265, L565-L570.
102. Yu, M., Wang, Z.W., Robinson, N.E. and Derksen, F.J. (1994) Modulation of bronchial smooth muscle function in horses with heaves. J. appl. Physiol. 77, 2149-2154.